Combining robust urine biomarkers to assess chronic kidney disease progression

BACKGROUND: Urinary biomarkers may improve the prediction of chronic kidney disease (CKD) progression. Yet, data reporting the applicability of most commercial biomarker assays to the detection of their target analyte in urine together with an evaluation of their predictive performance are scarce. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Bienaimé, Frank, Muorah, Mordi, Metzger, Marie, Broeuilh, Melanie, Houiller, Pascal, Flamant, Martin, Haymann, Jean-Philippe, Vonderscher, Jacky, Mizrahi, Jacques, Friedlander, Gérard, Stengel, Bénédicte, Terzi, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279781/
https://www.ncbi.nlm.nih.gov/pubmed/37285616
http://dx.doi.org/10.1016/j.ebiom.2023.104635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279781/
https://www.ncbi.nlm.nih.gov/pubmed/37285616
http://dx.doi.org/10.1016/j.ebiom.2023.104635

Ejemplares similares